Innovation and Internationalization

Innovation & Internationalization

Home < Innovation & Internationalization

Quality Management

International Quality, Care for Health

Qingdao Baheal Pharmaceutical prioritizes drug quality above all else. We actively incorporate internationally advanced production equipment, testing instruments, and cutting-edge technologies to establish a comprehensive quality management system covering the entire drug production lifecycle. Our manufacturing strictly adheres to international pharmaceutical standards, as well as the quality standards and processes approved by regulatory authorities. This ensures that every step of our production process consistently complies with the requirements of Good Manufacturing Practices (GMP).

Guided by the mission of “Optimizing Medical Scenarios through Scientific and Technological Innovation”, Qingdao Baheal Pharmaceutical devotes itself to enhancing drug accessibility by developing new pharmaceutical products and improving manufacturing processes, delivering greater health value to patients and safeguarding human health. Starting from strict source control of each single drug, the company implements rigorous raw material screening, refined production process management, comprehensive quality testing, and stringent final product review and release, until the medicines reach patients. Every step embodies Baheal’s care and commitment to human health.In its future development, Qingdao Baheal Pharmaceutical will continue to be driven by scientific and technological innovation and guided by patient needs, continuously enhancing its capabilities to make greater contributions to the cause of human health.

International Quality System Development

We have built and continuously optimized our quality system based on international standards and guidelines from NMPA, FDA, ICH, WHO, PIC/S, and ISPE. Firmly practicing the Quality by Design (QbD) philosophy, we foster a company-wide culture that prioritizes quality, ensuring our team remains grounded in strict compliance.

By maintaining the efficient operation of this high-standard management system, we are driven by technological innovation and guided by patient needs, striving to make greater contributions to global health.

Quality System Compliance History & Continuous Improvement

Since achieving a zero-observation status in our first U.S. FDA inspection in 2016, we have successfully passed multiple on-site inspections by both the NMPA and the FDA, along with annual audits by numerous clients. Notably, we maintained this zero-defect record in the 2024 FDA inspection.

We remain committed to rigorous risk control through robust quality management procedures. By prioritizing regulatory compliance and customer needs in our continuous improvement initiatives, we have earned high recognition from both auditors and clients.